The Notch signaling pathway is an evolutionarily conserved intercellular signaling mechanism essential for embryonic development in mammals. Mutations in the human JAGGED1 (JAG1) gene, which encodes a ligand for the Notch family of transmembrane receptors, cause the autosomal dominant disorder Alagille syndrome. We have examined the in vivo role of the mouse Jag1 gene by creating a null allele through gene targeting. Mice homozygous for the Jag1 mutation die from hemorrhage early during embryogenesis, exhibiting defects in remodeling of the embryonic and yolk sac vasculature. We mapped the Jag1 gene to mouse chromosome 2, in the vicinity of the Coloboma (Cm) deletion. Molecular and complementation analyses revealed that the Jag1 gene is functionally deleted in the Cm mutant allele. Mice heterozygous for the Jag1 null allele exhibit an eye dysmorphology similar to that of Cm/+ heterozygotes, but do not exhibit other phenotypes characteristic of Cm/+ mice or of humans with Alagille syndrome. These results establish the phenotype of Cm/+ mice as a contiguous gene deletion syndrome and demonstrate that Jag1 is essential for remodeling of the embryonic vasculature.
INTRODUCTION
The Notch signaling pathway is an evolutionarily conserved intercellular signaling mechanism and mutations in its components disrupt cell fate specification and embryonic development in organisms as diverse as insects, nematodes and mammals (reviewed in refs [1] [2] [3] . Recent work has established that two human diseases are caused by mutations in components of the Notch signaling pathway. Mutations in the NOTCH3 gene cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL; OMIM 125310), an inherited vascular dementia syndrome (4) . Mutations in the JAG1 gene, which encodes a ligand for Notch family receptors (5), cause Alagille syndrome (6, 7) . Alagille syndrome (OMIM 118450) is a pleiotropic developmental disorder that is one of the major forms of chronic liver disease in childhood. Alagille syndrome exhibits autosomal dominant inheritance and is characterized by neonatal jaundice and a paucity of intrahepatic bile ducts. Accompanying features of this syndrome include congenital heart defects, skeletal defects, ophthalmological abnormalities and characteristic facial appearance (reviewed in ref. 8) . The mutations originally found in the JAG1 gene in Alagille syndrome patients were inactivating mutations, generally leading to premature truncation of the JAGGED1 protein (6, 7) . Surveys of the types and frequency of JAG1 mutation in Alagille syndrome patients revealed that patients with large deletions encompassing the entire JAG1 gene had the same phenotype as patients with intragenic JAG1 mutations, suggesting that haploinsufficiency for the JAG1 gene was the cause of Alagille syndrome (9, 10) . In this paper, we have examined the role of the mouse Jag1 gene by creating a null allele and have characterized embryos and mice homozygous and heterozygous for this mutation. 
RESULTS

Disruption of the mouse Jag1 gene
To analyze the in vivo role of the Jag1 gene, a targeting vector was constructed that deletes 5 kb of genomic sequence near the 5′-end of the Jag1 gene (Fig. 1a) . The targeted allele deletes the C-terminal portion of the DSL domain, which is required for interaction of ligands with Notch family receptors (2, 11) . We refer to this mutant allele as Jag1 dDSL . The linearized targeting vector was electroporated into embryonic stem (ES) cells and germline transmission of the Jag1 dDSL allele was obtained for two targeted clones (Fig. 1b) . Mice heterozygous for the Jag1 dDSL mutant allele were grossly normal, viable and fertile. RT-PCR and western blot analyses indicated that no Jag1 RNA or protein was detectable in Jag1 dDSL /Jag1 dDSL homozygous mutant embryos (Fig. 2) .
Jag1 dDSL homozygous mutant embryos exhibit defects in vascular remodeling
To examine whether animals homozygous for the Jag1 dDSL mutation were viable, heterozygous F 1 animals were intercrossed and genotypes of the F 2 progeny determined 2-3 weeks after birth. No homozygotes were detected, indicating that the Jag1 dDSL allele is a recessive lethal mutation. To determine when homozygous mutant embryos were dying, embryos were isolated from timed matings. At embryonic day (E)10.5, Jag1 dDSL /Jag1 dDSL homozygotes could be identified easily due to hemorrhaging and the presence of yolk sacs lacking large blood vessels ( Fig. 3a and b) . Histological analysis confirmed widespread hemorrhage, in particular in the cranial mesenchyme ( Fig.  3c and d) . When isolated at E11.5, homozygous mutant embryos were either completely resorbed or were severely necrotic, while at E9.5 homozygous mutant embryos could not usually be distinguished from wild-type and heterozygous littermates (data not shown).
We visualized the vascular network of Jag1 dDSL /Jag1 dDSL embryos and littermate controls in whole mount preparations by staining with a monoclonal antibody to platelet endothelial cell adhesion molecule-1 (PECAM-1), which is a specific marker for vascular endothelial cells (12) . Defects in formation of the vascular system were observed both in the yolk sac and in the embryo of Jag1 dDSL /Jag1 dDSL homozygotes. Large vitelline blood vessels were present in the yolk sacs of control littermates, but large blood vessels were not present in the yolk sacs of Jag1 dDSL /Jag1 dDSL homozygous mutant embryos ( Fig. 3e and f) . The cranial region of the homozygous mutant embryos also exhibited vascular defects. The vascular network overlying the forebrain of the mutant embryos was not as intricate as that of heterozygous and wild-type littermates ( Fig. 3g and h) . Large blood vessels of the head had an abnormal appearance and a reduced diameter in the Jag1 dDSL /Jag1 dDSL homozygous mutant embryos ( Fig. 3i and j) .
Several groups have previously documented expression of the Jag1 gene (also referred to as the Serrate1 gene) in blood vessels in chick and mouse embryos (13) (14) (15) . However, Jag1 expression in cranial blood vessels that appear to be the first site of hemorrhage in Jag1 dDSL /Jag1 dDSL homozygous mutant embryos had not been reported. In situ hybridization of E10.5 wild-type embryos revealed Jag1 expression in cranial blood vessels (Fig.  3k ).
Jag1 dDSL homozygous mutant embryos do not exhibit defects in somitogenesis
Recent work has demonstrated that mutations in components of the Notch signaling pathway cause defects in segmentation and somite formation in mice (16) (17) (18) (19) (20) (21) . Since the Jag1 gene is expressed in the forming somite (13, 21, 22) , we analyzed Jag1 dDSL /Jag1 dDSL homozygous mutant embryos with several markers expressed in somites and in unsegmented paraxial mesoderm, including the genes Dll1 (23), Dll3 (24) , Lunatic fringe (Lfng; 21) and Uncx4.1 (25) . This analysis revealed no detectable defects in segmentation in the Jag1 dDSL /Jag1 dDSL mutant embryos (Fig. 4) .
The Jag1 gene is deleted in the Coloboma deletion
We mapped the chromosomal location of the Jag1 gene by interspecific backcross analysis to distal chromosome 2 ( Fig. 5 ), close to the semidominant Coloboma (Cm) mutation (26) . Cm/+ mice display several defects, including ophthalmic dysmorphology (e.g. iris colobomas), head bobbing, circling and profound hyperactivity (27) . Molecular analysis has revealed that Cm is a 1-2 cM deletion (26) .
To test whether the Jag1 gene mapped within the Cm deletion, we crossed a male Cm/+ hemizygote with Jag1 dDSL /+ female heterozygotes and isolated embryos at E10.5. Four out of 15 embryos from two different litters exhibited cranial hemorrhaging identical to Jag1 dDSL /Jag1 dDSL homozygous mutant embryos ( Fig. 6b-d) . When yolk sac DNA isolated from these abnormal embryos was genotyped with allele-specific PCR primers, the Jag1 dDSL mutant allele-specific primers amplified a band of the correct size, but the Jag1 wild-type allele-specific primers did not amplify any band (Fig. 6a) . This indicated that the portion of the Jag1 gene defined by our wild-type allele-specific PCR primers (the region encoding the DSL domain of the JAG1 protein) is deleted on the Cm chromosome. We have not determined if the entire coding sequence of the Jag1 gene is deleted on the Cm chromosome.
In a previous study, Theiler and Varnum (28) had examined embryos from the intercross of Cm/+ heterozygotes between E6.0 and E9.5 and concluded from this analysis that Cm/Cm homozygotes died before day 6 of gestation. However, Jag1 dDSL /Jag1 dDSL homozygous mutant embryos are generally not apparent phenotypically until ∼E10.5. We therefore examined embryos from the intercross of Cm/+ heterozygotes at E10.5. We isolated 38 embryos from five different litters of Cm/+ intercrosses. Ten out of 38 (26%) of these embryos were hemorrhagic (Fig.  6e ) and PCR analysis indicated that these embryos were Cm/Cm homozygotes (data not shown; see Materials and Methods). These results demonstrate that Cm/Cm homozygous mutant embryos do not die prior to E6, but die around E10.5 from vascular defects similar to those exhibited by Jag1 dDSL /Jag1 dDSL homozygous mutant embryos. 
Phenotypic effects in Jag1 dDSL /+ heterozygous mice
We examined Jag1 dDSL /+ adult heterozygotes for phenotypic abnormalities, since both Alagille syndrome in humans and phenotypes associated with the Cm deletion in mice are inherited as semidominant mutations. The Jag1 dDSL /+ mice exhibited an eye dysmorphology similar to that of Cm/+ mice (Table 1 and Fig.  7 ). The penetrance of the eye dysmorphology phenotype in Jag1 dDSL /+ mice was high (∼80%) on a mixed genetic background and increased to 100% on a predominantly C57BL/6J background (Table 1) . However, the Jag1 dDSL /+ heterozygotes did not appear to display the head bobbing, circling and hyperactivity characteristic of Cm/+ mice (27) . Jag1 dDSL /+ adult heterozygotes (n = 10) were examined for other phenotypic abnormalities associated with Alagille syndrome in humans (e.g. defects of the liver, heart and axial skeleton), but no defects in these structures were observed in the Jag1 dDSL /+ mice. 
DISCUSSION
Defects in vascular remodeling in Jag1 dDSL homozygous mutant embryos
In this report we have demonstrated that the Notch ligand encoded by the Jag1 gene plays an essential role during embryonic development in mice. Mice homozygous for a targeted null mutation of the Jag1 gene die at E10 due to vascular defects. During the early stages of vascular development in both the embryo and the yolk sac, endothelial cell precursors differentiate and coalesce into a network of homogeneously sized primitive blood vessels (the primary vascular plexus) in a process termed vasculogenesis. This primary vascular plexus is then remodeled into the large and small vessels of the mature vascular system by the process of angiogenesis (29, 30) . In the yolk sac of Jag1 dDSL /Jag1 dDSL homozygous mutant embryos, the primary vascular plexus appeared to form normally, indicating that there were no apparent defects in vasculogenesis in the homozygous mutants. However, the Jag1 dDSL /Jag1 dDSL homozygous mutant embryos failed to remodel the primary vascular plexus to form the large vitelline blood vessels, a process that occurs by angiogenesis. The cranial region of the homozygous mutant embryos also exhibited a defect in vascular remodeling. The vascular network overlying the forebrain of the mutant embryos was not as intricate as that of control littermates and the large blood vessels of the head had an abnormal appearance and a reduced diameter. These abnormalities suggest that the Jag1 dDSL /Jag1 dDSL homozygous mutant embryos exhibit defects in angiogenic vascular remodeling both in the yolk sac and in the embryo. Zimrin et al. have previously demonstrated a connection between Jag1 expression and angiogenesis (31) . They isolated the human Jag1 cDNA in a differential display screen for genes induced in an in vitro angiogenesis model and also showed that administration of Jag1 antisense oligonucleotides could modulate in vitro angiogenesis (31) . Our results extend these findings by demonstrating that expression of the Jag1 gene plays an important role in vascular development during embryogenesis in at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from mice, in particular during angiogenic vascular remodeling. Taken together with the finding that mutations of the human Notch3 gene cause the systemic vascular disease CADASIL (4), these results indicate that components of the Notch signaling pathway are essential both for vascular development in embryos and maintenance of a healthy vascular system in adults.
Absence of somite defects in Jag1 dDSL homozygous mutant embryos
Recent work has demonstrated that mutations in components of the Notch signaling pathway cause defects in somite formation in mice. Notch pathway mutants exhibiting defects in somitogenesis include the genes encoding the Notch1 receptor (16, 17) , the ligands Dll1 (18) and Dll3 (19) and Lfng (20, 21) , which encodes a secreted protein that regulates Notch signaling (22, 32) . We analyzed Jag1 dDSL /Jag1 dDSL homozygous mutant embryos with several markers expressed in somites and in unsegmented paraxial mesoderm and found no detectable defects in segmentation in the homozygous mutant embryos. This result supports our previous finding that expression of the Jag1 gene in the forming somite is unaffected in Lfng -/-mutant embryos (21) . We have also demonstrated previously that mice homozygous for a null mutation of the related Jagged2 (Jag2) gene, while displaying a variety of phenotypic defects, exhibit no defects in somite formation (33) . These findings reveal a division of function among the Notch family ligands. Notch signaling mediated by the Delta family ligands encoded by the Dll1 and Dll3 genes is essential for proper somite formation, but signaling mediated by the Serrate family ligands encoded by the Jag1 and Jag2 genes is not required for somitogenesis in mice.
Gene dosage-sensitive phenotypic effects in Jag1 dDSL /+ heterozygous mice While our RT-PCR and western blot data indicated that the Jag1 dDSL allele is most likely a null (amorphic) allele, the most stringent genetic test to determine whether a particular mutation is a null allele is to test that mutation over a deletion of the locus in question (34) . Our finding that at least a portion of the Jag1 gene is deleted on the Cm mutant chromosome permitted us to perform this classic genetic test. Since the phenotype of the Jag1 dDSL /Cm mutant embryos appeared identical to that of Jag1 dDSL /Jag1 dDSL homozygotes, this analysis confirmed that the targeted Jag1 dDSL mutation is a null allele.
Since both Alagille syndrome in humans and phenotypes associated with the Cm deletion in mice are inherited as semidominant mutations, we examined Jag1 dDSL /+ adult heterozygotes for phenotypic abnormalities. The Jag1 dDSL /+ mice exhibited an eye dysmorphology similar to that of Cm/+ mice, but did not appear to display the head bobbing, circling and hyperactivity characteristic of Cm/+ mice (27) . Similarly, Alagille syndrome patients often display ophthalmological abnormalities, typically including anterior chamber defects and posterior embryotoxon (8) . The ophthalmological abnormalities displayed by the Jag1 dDSL /+ adult heterozygotes are somewhat different in type and are more severe than the abnormalities typically displayed by Alagille syndrome patients. Both Jag1 dDSL /+ and Cm/+ mice exhibit iris colobomas (Fig. 7) . The iris, at its periphery, is continuous with the ciliary body. During development of the eye, the Jag1 gene is expressed in the ciliary body (35, 36) . While we do not currently understand at a mechanistic level how reduction of Jag1 gene dosage leads to the formation of iris colobomas, this phenotype correlates well with the pattern of expression of the Jag1 gene during eye development.
In contrast to the presence of eye dysmorphologies in the Jag1 dDSL /+ heterozygotes, these mice did not appear to exhibit other phenotypic abnormalities (e.g. defects of the liver, heart and axial skeleton) associated with Alagille syndrome in humans. Phenotypes sensitive to gene dosage are characteristic of mutations of Notch pathway components in Drosophila (reviewed in ref. 37 ). The eye phenotype of the Jag1 dDSL /+ mice is the first documented instance of a gene dosage-sensitive phenotype in any of the Notch pathway mutants in mice. However, the Jag1 dDSL /+ mice do not appear to represent a good animal model for Alagille syndrome.
The phenotypes of Cm/+ mice constitute a contiguous gene deletion syndrome Several human disorders (termed contiguous gene deletion syndromes) are associated with either cytogenetically detectable or submicroscopic chromosomal deletions (38) . In mice, the Cm deletion has been shown to encompass the genes encoding phospholipase C isoform β-1 and the synaptosome-associated protein (25 kDa; Snap25) (26) . Expression of a transgene encoding the SNAP25 protein rescues the hyperactivity of Cm/+ hemizygotes, but not the ophthalmic dysmorphology or head bobbing (27) . Our molecular and genetic data indicate that the Cm deletion also encompasses at least a portion of the Jag1 gene and that loss of the Jag1 gene is responsible for the ophthalmic dysmorphology of Cm/+ hemizygotes. These data indicate that the phenotype of Cm/+ mice constitutes a contiguous gene deletion syndrome.
MATERIALS AND METHODS
Isolation of genomic and cDNA clones and targeting vector construction
Genomic clones of the Jag1 gene were obtained by screening a P1 genomic library made from genomic DNA of 129/Sv strain mouse embryonic stem cells (Genome Systems, St Louis, MO) with PCR primers corresponding to sequences specific to the mouse Jag1 cDNA. Positive P1 clones were analyzed by restriction mapping and Southern hybridization. Fragments that hybridized to Jag1 cDNA clones were subcloned and the exon-intron organization of part of the Jag1 gene was determined by nucleotide sequencing.
The targeting vector was constructed from an 11 kb genomic subclone of the Jag1 gene. The 3′ arm was a 2.3 kb HindIII genomic fragment that was subcloned downstream of a PGK-neo expression cassette (39) . To construct the 5′ arm, an oligonucleotide (5′-AAGCAATTGCGCCAAAGCCATAG-3′) complementary to a sequence in the middle of the exon encoding the DSL domain of the JAG1 protein was used as a PCR primer for amplification on a Jag1 genomic subclone. The amplified fragment was then subcloned upstream of the PGK-neo cassette. This disrupted the exon encoding the DSL domain and resulted in the deletion of a 5.0 kb genomic fragment containing the exons encoding the C-terminal half of the DSL domain and half of the first EGF repeat of the JAG1 protein. In this paper, we refer to this allele as Jag1 dDSL (the nomenclature for this allele assigned by at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from the International Committee on Standardized Genetics Nomenclature for Mice is Jag1 tm1Grid ). A HSV-tk cassette (40) was also introduced to allow negative selection against random integration of the targeting vector.
Electroporation, selection and screening of ES cells and mouse genotyping
CJ7 ES cells were electroporated with 25 µg of linearized targeting vector, selected, screened and injected into blastocysts from C57BL/6J mice as previously described (41) . Animals were genotyped by Southern blot analysis or by PCR. PCR primers for the Jag1 wild-type allele were JG1 (5′-TCTCACTCAGGCATGA-TAAACC-3′) and JG2 (5′-TAACGGGGACTCCGGACA-GGG-3′). Primers for the Jag1 dDSL allele were JG1 and JG4 (5′-GGTGCTGTCCATCTGCACGAG-3′). For RT-PCR, the Jag1 primers were JGRT1 (5′-AGTGCCCAGAGCTTGAACCG-3′) and JGRT2 (5′-CTAAGGCTGCCATCACCATTAGG-3′). Control primers for peptidylprolyl isomerase B (Ppib) were (5′-ATAT-GAAGGTGCTCTTCGCCGCCG-3′) and (5′-CATTGGTGTC-TTTGCCTGCATTGGC-3′).
Examination of Cm/Cm embryos
Male Cm/+ heterozygous mice on the C3H/HeSnJ background were backcrossed for two generations to C57BL/6J mice. Cm/+ heterozygous adult progeny were genotyped by examination for the presence of iris colobomas. These Cm/+ heterozygotes were intercrossed, and progeny were isolated at E10.5. Embryos were fixed for morphological analysis and DNA was prepared from the yolk sac of each embryo. Yolk sac DNA was examined for the presence of the wild-type Jag1 gene by allele-specific PCR using the primers JG1 and JG2 (see above). Primers for the wild-type Notch2 gene, which is located on chromosome 3 (42), were used as a positive control for DNA integrity. Primers for the Notch2 wild-type allele were (5′-TCTCCATATTGATGAGCCATGC-3′) and (5′-CCAGTGTGCCACAGGTAAGTG-3′).
Western blot analysis
Polyclonal antiserum (J59) specific for the cytoplasmic domain of rat JAG1 was raised by immunizing a rabbit with a bacterially expressed protein consisting of amino acids 1101-1219 inclusive of rat JAG1 fused to glutathione S-transferase. Embryo lysates (at E10.5) were separated on 8% SDS-PAGE gels and transferred to PVDF membrane. The membrane was incubated with affinity purified J59 antiserum and with goat anti-rabbit-horseradish peroxidase conjugate (Cappel, Durham, NC). The horseradish peroxidase signal was detected using chemiluminescence substrate (ECL; Amersham, Arlington Heights, IL).
Histology, in situ hybridization and immunohistochemistry
Embryos were dissected and DNA was prepared from the yolk sacs or tails for genotyping. Embryos for histological analysis were fixed in Bouin's fixative. Fixed embryos were dehydrated through graded alcohols, embedded in paraffin, sectioned and stained with hematoxylin and eosin. Embryos for in situ hybridization were fixed overnight at 4_C in 4% paraformaldehyde in phosphate-buffered saline (PBS). Embryos for immunohistochemistry were fixed in 4% paraformaldehyde in PBS and stained with a monoclonal anti-PECAM-1 antibody (Pharmingen, San Diego, CA). For analysis of Jag1 dDSL /+ heterozygous adult mice, animals were examined with a slit lamp for eye defects. Livers and hearts from these Jag1 dDSL /+ heterozygotes (which all displayed eye defects; n = 10 Jag1 dDSL /+ heterozygotes) and from age-matched littermate controls were dissected, fixed in Bouin's fixative and sectioned. Skeletons were examined by X-ray analysis.
Chromosomal localization
We determined the chromosomal location of the Jag1 gene by interspecific backcross analysis. C57BL/6J and M.spretus DNAs were digested with several enzymes and analyzed for informative restriction fragment length polymorphisms (RFLPs) by Southern blotting using a Jag1 genomic probe (a 2.2 kb EcoRI-StuI fragment). An EcoRV RFLP was then used to analyze Southern blots of EcoRV-digested DNA from 94 N 2 progeny from the cross (C57BL/6JEi×SPRET/Ei)F 1 ×SPRET/Ei from the Jackson Laboratory BSS interspecific backcross panel (43) . The presence or absence of the C57BL/6J-specific EcoRV fragment was followed in the backcross mice. Raw typing data for this cross are available at http://www.jax.org/resources/documents/cmdata . Centimorgan postitions for Cm and Snap25 (which have not been mapped in the Jackson BSS backcross) were obtained from the Mouse Genome Database (http://www.informatics.jax.org/locus.html ).
